Time-in-range (TIR) data generated from continuous glucose monitoring devices is a powerful metric that people living with diabetes can use to gain a better picture of their glycemic control and make more informed decisions. TIR is the percentage of time a person’s glucose values are within the recommended target range and is effective in capturing dynamic variations in glucose levels.
CGM devices have enabled people living with diabetes to monitor their glucose levels and make informed decisions about their food and exercise. CGM devices can help determine a person’s control over diabetes by looking at their ‘time in range’ (TIR) between 70 mg/dL and 180 mg/dL. A consensus study found that people with a TIR of more than 80% have a lower risk of wound infection and ICUs.
Additionally, even a 10% reduction in TIR can increase the risk of diabetes-related eye diseases (retinopathy) by 64% and the level of albumin protein in one’s urine (microalbuminuria) by 40%. Dr. Prashanth Subramanian, Head of Medical Affairs, Emerging Asia & India, Abbott Diabetes Care says, “This can make people aware of trends promptly guiding them to take lifestyle or treatment decisions to be in better control of their glucose levels.”
